During this immune activation period, the release of pro-inflammatory factors such as IL-1β and TNF-α can promote the migration of monocytes, neutrophils, and platelets, enhancing the action of immune cells against the tumor [34,35]. This evidence concerns the gene IL1B and neoplasm.